Amalgamated Bank reported strong Q2 2026 results with earnings per share of $1.10, beating estimates by 10%, and revenues of $98.36 million, up nearly 7% from forecasts. The bank achieved record net income of $34.8 million and maintained a core efficiency ratio below 50%, reflecting solid operational management. With returns on assets and equity above key thresholds, management raised its full-year 2026 financial guidance, signaling confidence in continued growth and profitability. This performance highlights the bank's strong balance sheet and unique deposit base, supporting its positive outlook.
Thermo Fisher Scientific reported strong Q2 results with adjusted EPS of $6.03 and nearly $12 billion in sales, surpassing analyst estimates. The company saw broad growth across all segments, including Life Sciences Solutions, Analytical Instruments,...
Argenx reported strong Q2 product net sales of $1.5 billion, a 60% increase year-over-year, driven by robust sales of its autoimmune treatment Vyvgart. RBC Capital raised its price target for Argenx stock to $1,025 from $945 and maintained an Outperf...
TotalEnergies reported strong financial results for Q2 2026, with earnings per share (EPS) of $2.68, slightly above analyst expectations of $2.66. The company’s revenue reached $57.10 billion, surpassing estimates of $55.13 billion, driven by higher ...
Verizon Communications is set to report its Q2 2026 earnings with analysts expecting an EPS of $1.27 and revenue around $35.16 to $35.31 billion. The company is undergoing major restructuring, including selling 274 stores and cutting over 13,000 jobs...
Tenet Healthcare Corporation's stock price targets have declined, reflecting analyst caution amid upcoming Q2 earnings. The company may experience pressure from lower patient days, but this could be offset by higher revenue per patient and growth in ...
